Management of hair loss

Dermatologic Clinics

Volumn 23, Issue 2, 2005, Pages 227-243

  Ross, Elizabeth K ^a   Shapiro, Jerry ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BETAMETHASONE DIPROPIONATE; BUTANEDIOL; CHLORMADINONE ACETATE; CORTICOSTEROID; CYPROTERONE ACETATE; DIENOGEST; DIPHENCYPRONE; DITHRANOL; DROSPIRENONE; DROSPIRENONE PLUS ETHINYLESTRADIOL; FINASTERIDE; FLUOCINOLONE; FLUTAMIDE; KETOCONAZOLE; METHYLPREDNISOLONE; MINOXIDIL; ORAL CONTRACEPTIVE AGENT; PREDNISONE; PROPYLENE GLYCOL; PSORALEN; SHAMPOO; SPIRONOLACTONE; SQUARIC ACID DIBUTYL ESTER; STEROID; TAR; TRIAMCINOLONE ACETONIDE;

ACNE; AGE DISTRIBUTION; ALOPECIA; ALOPECIA AREATA; ANAPHYLAXIS; BLINDNESS; BLISTER; BREAST CANCER; BURN; CARDIOTOXICITY; CLINICAL FEATURE; CLINICAL TRIAL; COMORBIDITY; CONTACT DERMATITIS; CONTACT URTICARIA; CREAM; DERMATITIS; DERMOGRAPHISM; DIET; DRUG ABSORPTION; DRUG CONTRAINDICATION; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG FEVER; DRUG HYPERSENSITIVITY; DRUG INDICATION; DRUG METABOLISM; ECZEMA; ERECTILE DYSFUNCTION; ERYTHEMA; ERYTHEMA MULTIFORME; ESTHETIC SURGERY; FACE EDEMA; FEMINIZATION; FLU LIKE SYNDROME; FOLLICULITIS; FOOD AND DRUG ADMINISTRATION; GLEASON SCORE; HAIR COLOR; HAIR GROWTH; HAIR LOSS; HAIR PROSTHESIS; HAIR TRANSPLANTATION; HEALTH CARE PLANNING; HUMAN; HYPERTRICHOSIS; HYPOPIGMENTATION; LENTIGINOSIS; LIBIDO DISORDER; LIVER TOXICITY; LOTION; LYMPHADENOPATHY; MOOD DISORDER; NAUSEA; NONHUMAN; OINTMENT; PATIENT COMPLIANCE; PATIENT SATISFACTION; PIGMENT DISORDER; PREGNANCY COMPLICATION; PRIORITY JOURNAL; PROSTHESIS; PRURITUS; PUVA; REMISSION; REVIEW; SCREENING TEST; SEMEN ABNORMALITY; SIDE EFFECT; SKIN ATROPHY; SKIN CANCER; SKIN IRRITATION; TELANGIECTASIA; TREATMENT FAILURE; TREATMENT OUTCOME; TREATMENT WITHDRAWAL; ULTRAVIOLET A RADIATION; VITAMIN SUPPLEMENTATION; VITILIGO; WEIGHT GAIN; WHOLE BODY RADIATION;

EID: 17044415679     PISSN: 07338635     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.det.2004.09.008     Document Type: Review

References (93)

1. E.A. Olsen, A.G. Messenger, and J. Shapiro Recommended guidelines for the evaluation and treatment of male and female pattern hair loss J Am Acad Dermatol 52 2005 301 311
2. E.A. Olsen, F.E. Dunlap, and T. Funicella A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men J Am Acad Dermatol 47 2002 377 385
3. V.H. Price, E. Menefee, and P.C. Strauss Changes in hair weight and hair count in men with androgenetic alopecia, after application of 5% and 2% topical minoxidil, placebo, or no treatment J Am Acad Dermatol 41 1999 717 721
4. K.D. Kaufman, E.A. Olsen, and D. Whiting Finasteride in the treatment of men with androgenetic alopecia J Am Acad Dermatol 39 1998 578 589
5. J. Leyden, F. Dunlap, and B. Miller Finasteride in the treatment of men with frontal male pattern hair loss J Am Acad Dermatol 40 1999 930 937
6. Finasteride Male Pattern Hair Loss Group Long-term (5-year) multinational experience with finasteride 1 mg in the treatment of men with androgenetic alopecia Eur J Dermatol 12 2002 38 49
7. D.A. Whiting, E.A. Olsen, and R. Savin Efficacy and tolerability of finasteride 1 mg in men aged 41 to 60 years with male pattern hair loss Eur J Dermatol 13 2003 150 160
8. Olsen E.A., Shapiro J. Managing the patient with androgenetic alopecia: current concepts in diagnosis and treatment (slides and lecture notes). Presented at the Rogaine Speakers Bureau, Pharmacia Corporation, 2001
9. E.S. Friedman, P.M. Friedman, D.E. Cohen, and K. Washenik Allergic contact dermatitis to topical minoxidil solution: etiology and treatment J Am Acad Dermatol 46 2002 309 312
10. J. Shapiro Safety of topical minoxidil solution: a one-year, prospective, observational study J Cutan Med Surg 7 2003 322 329
11. Monograph on Proscar. Merck & Co., Inc: Whitehouse Station (NJ); April 2004
12. L. Green, D.K. Wysowski, and J.L. Fourcroy Gynecomastia and breast cancer during finasteride therapy N Engl J Med 335 11 1996 823
13. I.M. Thompson, P.J. Goodman, and C.M. Tangen The influence of finasteride on the development of prostate cancer N Engl J Med 349 3 2003 213 222
14. Monograph on Propecia. Merck & Co., Inc: Whitehouse Station (NJ); October 2003
15. A.R. Diani, M.J. Mulholland, and K.L. Shull Hair growth effects of oral administration of finasteride, a steroid 5α-reductase inhibitor, alone and in combination with topical minoxidil in the balding stumptail macaque J Clin Endocrinol Metab 74 2 1992 345 350
16. S. Khandpur, M. Suman, and B.S. Reddy Comparative efficacy of various treatment regimens for androgenetic alopecia in men J Dermatol 29 2002 489 498
17. V.M. Meidan, and E. Touitou Treatments for androgenetic alopecia and alopecia areata: current options and future prospects Drugs 61 1 2001 53 69
18. E.A. Olsen Pattern hair loss in men and women E.A. Olsen Disorders of hair growth: diagnosis and treatment 2nd edition 2003 McGraw-Hill New York 321 363
19. C. Piérard-Franchimont, P. De Doncker, G. Cauwenbergh, and G.E. Piérard Ketoconazole shampoo: effect of long-term use in androgenic alopecia Dermatology 196 1998 474 477
20. G.S. Bazzano, N. Terezakis, and W. Galen Topical tretinoin for hair growth promotion J Am Acad Dermatol 15 1986 880 893
21. J. Shapiro Androgenetic alopecia: pathogenesis, clinical features and practical medical treatment Hair loss: principles of diagnosis and management of alopecia 2002 Martin Dunitz London 83 121
22. J. Kantor, L.J. Kessler, D.G. Brooks, and G. Cotsarelis Decreased serum ferritin is associated with alopecia in women J Invest Dermatol 121 2003 985 988
23. A. Tosti, M. Iorizzo, and C. Vincenzi Finasteride treatment may not prevent telogen effluvium after minoxidil withdrawal Arch Dermatol 139 2003 1221 1222
24. M.R. Avram, J.P. Cole, and M. Gandelman The potential role of minoxidil in the hair transplantation setting Dermatol Surg 28 2002 894 900
25. V.H. Price Androgenetic alopecia in adolescents Cutis 71 2003 115 121
26. R.L. DeVillez, J.P. Jacobs, C.A. Szpunar, and M.L. Warner Androgenetic alopecia in the female Arch Dermatol 130 1994 303 307
27. P. Vexiau, C. Chaspoux, and P. Boudou Effects of minoxidil 2% vs. cyproterone acetate treatment on female androgenetic alopecia: a controlled, 12-month randomized trial Br J Dermatol 146 2002 992 999
28. R.P.R. Dawber, and J. Rundegren Hypertrichosis in females applying minoxidil topical solution and in normal controls J Eur Acad Dermatol Venereol 17 2003 271 275
29. V.C. Fiedler, and A.C. Gray Diffuse alopecia: telogen hair loss E.A. Olsen Disorders of hair growth: diagnosis and treatment 2nd edition 2003 McGraw-Hill New York 303 321
30. B.A. Schwetz New oral contraceptive JAMA 286 2001 527
31. D. Raudrant, and T. Rabe Progestogens with antiandrogenic properties Drugs 63 5 2003 463 492
32. A.W. Lucky, D.J. Piacquadio, and C.M. Ditre A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss J Am Acad Dermatol 50 2004 541 553
33. E. Carmina, and R.A. Lobo Treatment of hyperandrogenic alopecia in women Fertil Steril 79 2003 91 95
34. E. Diamanti-Kandarakis Current aspects of antiandrogen therapy in women Curr Pharm Des 5 1999 707 723
35. M.E. Sawaya Antiandrogens and androgen inhibitors S.E. Wolverton Comprehensive dermatologic drug therapy 2001 WB Saunders Philadephia 385 402
36. V.H. Price, J.L. Roberts, and M. Hordinsky Lack of efficacy of finasteride in postmenopausal women with androgenetic alopecia J Am Acad Dermatol 43 2000 768 776
37. K.E. Thai, and R.D. Sinclair Finasteride for female androgenetic alopecia Br J Dermatol 147 2002 812 813
38. K.W. Shum, D.R. Cullen, and A.G. Messenger Hair loss in women with hyperandrogenism: four cases responding to finasteride J Am Acad Dermatol 47 2002 733 739
39. N.F. Goodman, M.B. Bledsoe, and R.H. Cobin American Association of Clinical Endocrinologists medical guidelines for the clinical practice for the diagnosis and treatment of hyperandrogenic disorders Endocr Pract 7 2 2001 120 134
40. R.A. Lobo What are the key features of importance in polycystic ovary syndrome? Fertil Steril 80 2 2003 259 261
41. J. Shapiro Telogen effluvium: acute and chronic Hair loss: principles of diagnosis and management of alopecia 2002 Martin Dunitz London 121 135
42. A. Tosti, B.M. Piraccini, and D.J.J. van Neste Telogen effluvium after allergic contact dermatitis of the scalp Arch Dermatol 137 2001 187 190
43. D.A. Whiting Chronic telogen effluvium: increased scalp hair shedding in middle-aged women J Am Acad Dermatol 35 1996 899 906
44. L. Gip, A. Lodin, and L. Molin Alopecia areata. A follow-up investigation of outpatient material Acta Dermatol Venereol 49 1969 180 188
45. S.P. MacDonald Hull, M.L. Wood, P.E. Hutchinson, M. Sladden, and A.G. Messenger Guidelines for the management of alopecia areata Br J Dermatol 149 2003 692 699
46. G. Mancuso, A. Balducci, and C. Casadio Efficacy of betamethasone valerate foam formulation in comparison with betamethasone dipropionate lotion in the treatment of mild-to-moderate alopecia areata: a multicenter, prospective, randomized, controlled, investigator-blinded trial Int J Dermatol 42 2003 572 575
47. S. Charuwichitratana, P. Wattanakrai, and S. Tanrattanakorn Randomized double-blind placebo-controlled trial in the treatment of alopecia areata with 0.25% desoximetasone cream Arch Dermatol 136 2000 1276 1277
48. J.L. Leyden, and A.M. Kligman Treatment of alopecia areata with steroid solution Arch Dermatol 106 1972 924
49. F. Pascher, S. Kurtin, and R. Andrade Assay of 0.2 percent fluocinolone acetonide cream for alopecia areata and totalis Dermatologica 141 1970 193 202
50. A. Tosti, B.M. Piraccini, M. Pazzaglia, and C. Vincenzi Clobetasol propionate 0.05% under occlusion in the treatment of alopecia totalis/universalis J Am Acad Dermatol 49 2003 96 98
51. N. Orentreich, H.M. Sturm, A.I. Weidman, and A. Pelzig Local injection of steroids and hair regrowth in alopecias Arch Dermatol 82 1960 894 902
52. D. Porter, and J.L. Burton A comparison of intra-lesional triamcinolone hexacetonide and triamcinolone acetonide in alopecia areata Br J Dermatol 85 1971 272 273
53. E. Abell, and D.D. Munro Intralesional treatment of alopecia areata with triamcinolone acetonide by jet injector Br J Dermatol 88 1973 55 59
54. E.P. Kubeyinje Intralesional triamcinolone acetonide in alopecia areata amongst 62 Saudi Arabs East Afr Med J 71 1994 674 675
55. A.M. Downs, J.T. Lear, and C.T. Kennedy Anaphylaxis to intradermal triamcinolone acetonide Arch Dermatol 134 1998 1163 1164
56. V.J. Selmanowitz, and N. Orentreich Cutaneous corticosteroid injection and amaurosis. Analysis for cause and prevention Arch Dermatol 110 1974 729 734
57. R. Michalowski, and L. Kuczynska Long-term intramuscular triamcinolone acetonide therapy in alopecia areata totalis and universalis Arch Dermatol Res 261 1978 73 76
58. E.A. Olsen, S.C. Carson, and E.A. Turney Systemic steroids with or without 2% topical minoxidil in the treatment of alopecia areata Arch Dermatol 128 1992 1467 1473
59. A. Friedli, M.P. Labarthe, E. Engelhardt, R. Feldmann, D. Salomon, and J.H. Saurat Pulse methylprednisolone therapy for severe alopecia areata: an open prospective study of 45 patients J Am Acad Dermatol 39 1998 597 602
60. J.L. Burton, and S. Shuster Large doses of glucocorticoid in the treatment of alopecia areata Acta Dermatol Venereol 55 1975 493 496
61. A. Friedli, D. Salomon, and J.H. Saurat High-dose pulse corticosteroid therapy: is it indicated for severe alopecia areata? Dermatology 202 2001 191 192
62. M.G. Wilkerson, T.H. Connor, J. Henkin, J.K. Wilkin, and T.S. Matney Assessment of diphenylcyclopropenone for photochemically induced mutagenicity in the Ames assay J Am Acad Dermatol 17 1987 606 611
63. R. Happle, K.J. Kalveram, U. Buchner, K.E. Happle, W. Goggelmann, and K.H. Summer Contact allergy as a therapeutic tool for alopecia areata: application of squaric acid dibutylester Dermatologica 161 1980 289 297
64. C.K. Rokhsar, J.L. Shupack, J.J. Vafai, and K. Washenik Efficacy of topical sensitizers in the treatment of alopecia areata J Am Acad Dermatol 39 1998 751 761
65. M.C. Wiseman, J. Shapiro, N. MacDonald, and H. Lui Predictive model for immunotherapy of alopecia areata with diphencyprone Arch Dermatol 137 2001 1063 1068
66. P.H. van der Steen, H.M. van Baar, R. Happle, J.B. Boezeman, and C.M. Perret Prognostic factors in the treatment of alopecia areata with diphenylcyclopropenone J Am Acad Dermatol 24 1991 227 230
67. G. Micali, R.L. Cicero, M.R. Nasca, and A. Sapuppo Treatment of alopecia areata with squaric acid dibutylester Int J Dermatol 35 1996 52 56
68. G. Orecchia, P. Malagoli, and L. Santagostino Treatment of severe alopecia areata with squaric acid dibutylester in pediatric patients Pediatr Dermatol 11 1994 65 68
69. M.L. Schuttelaar, J.J. Hamstra, and E.P. Plinck Alopecia areata in children: treatment with diphencyprone Br J Dermatol 135 1996 581 585
70. A. Tosti, M.P. De Padova, G. Minghetti, and S. Veronesi Therapies versus placebo in the treatment of patchy alopecia areata J Am Acad Dermatol 15 1986 209 210
71. A. Tosti, M.S. Guidetti, F. Bardazzi, and C. Misciali Long-term results of topical immunotherapy in children with alopecia totalis or alopecia universalis J Am Acad Dermatol 35 1996 199 201
72. E. Higgins, and A. du Vivier Topical immunotherapy: unapproved uses, dosages, or indications Clin Dermatol 20 2002 515 521
73. G. Orecchia, and L. Perfetti Alopecia areata and topical sensitizers: allergic response is necessary but irritation is not Br J Dermatol 124 1991 509
74. J. Shapiro Alopecia areata: pathogenesis, clinical features, diagnosis and practical management Hair loss: principles of diagnosis and management of alopecia 2002 Martin Dunitz London 19 83
75. A. Tosti, B.M. Piraccini, C. Misciali, and C. Vincenzi Lentiginous eruption due to topical immunotherapy Arch Dermatol 139 2003 544 545
76. C. Schmoeckel, I. Weissmann, G. Plewig, and O. Braun-Falco Treatment of alopecia areata by anthralin-induced dermatitis Arch Dermatol 115 1979 1254 1255
77. D.A. Nelson, and R. Spielvogel Anthralin therapy for alopecia areata Int J Dermatol 24 1985 606 607
78. V.C. Fiedler-Weiss, and C.M. Buys Evaluation of anthralin in the treatment of alopecia areata Arch Dermatol 123 1987 1491 1493
79. A. Lassus, A. Eskelinen, and E. Johansson Treatment of alopecia areata with three different PUVA modalities Photodermatology 1 1984 141 144
80. E. Healy, and S. Rogers PUVA treatment for alopecia areata-does it work? A retrospective review of 102 cases Br J Dermatol 129 1993 42 44
81. C.R. Taylor, and J.L. Hawk PUVA treatment of alopecia areata partialis, totalis and universalis: audit of 10 years' experience at St John's Institute of Dermatology Br J Dermatol 133 1995 914 918
82. K.J. Whitmont, and A.J. Cooper PUVA treatment of alopecia areata totalis and universalis: a retrospective study Australas J Dermatol 44 2003 106 109
83. D.A. Fenton, and J.D. Wilkinson Topical minoxidil in the treatment of alopecia areata BMJ 287 1983 1015 1017
84. J.P. Vestey, and J.A. Savin A trial of 1% minoxidil used topically for severe alopecia areata Acta Dermatol Venereol 66 1986 179 180
85. V.H. Price Double-blind, placebo-controlled evaluation of topical minoxidil in extensive alopecia areata J Am Acad Dermatol 16 1987 730 736
86. A.F. Fransway, and S.A. Muller 3 percent topical minoxidil compared with placebo for the treatment of chronic severe alopecia areata Cutis 41 1988 431 435
87. R.E. Ranchoff, W.F. Bergfeld, W.D. Steck, and S.J. Subichin Extensive alopecia areata. Results of treatment with 3% topical minoxidil Cleve Clin J Med 56 1989 149 154
88. V.C. Fiedler-Weiss, D.P. West, C.M. Buys, and J.A. Rumsfield Topical minoxidil dose-response effect in alopecia areata Arch Dermatol 122 1986 180 182
89. V.H. Price Topical minoxidil in extensive alopecia areata, including 3-year follow-up Dermatologica 175 Suppl 2 1987 36 41
90. J.M. Maitland, R.D. Aldridge, R.A. Main, M.I. White, and A.D. Ormerod Topical minoxidil in the treatment of alopecia areata BMJ 288 1984 794
91. V.C. Fiedler Alopecia areata: current therapy J Invest Dermatol 96 1991 69S 70S
92. J. Shapiro, J. Tan, V. Ho, and V. Tron Treatment of severe alopecia areata with topical diphenylcyclopropenone and 5% minoxidil: a clinical and immunopathologic evaluation J Invest Dermatol 104 1995 36S
93. V.C. Fiedler, A. Wendrow, G.J. Szpunar, C. Metzler, and R.L. DeVillez Treatment-resistant alopecia areata. Response to combination therapy with minoxidil plus anthralin Arch Dermatol 126 1990 756 759